Progressive in vivo development of resistance to cefiderocol in Pseudomonas aeruginosa

We report in vivo development of cefiderocol (FDC) resistance among four sequential Pseudomonas aeruginosa clinical isolates ST244 recovered from a single patient, without exposure to FDC, which raises concern about the effectiveness of this novel drug. The first recovered P. aeruginosa isolate (P-0...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadek, Mustafa, Le Guern, Rémi, Kipnis, Eric, Gosset, Philippe, Poirel, Laurent, Dessein, Rodrigue, Nordmann, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816264/
https://www.ncbi.nlm.nih.gov/pubmed/36376766
http://dx.doi.org/10.1007/s10096-022-04526-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816264/
https://www.ncbi.nlm.nih.gov/pubmed/36376766
http://dx.doi.org/10.1007/s10096-022-04526-0

Ejemplares similares